Herpes zoster vaccine lowers heart disease risk

A new study reveals the herpes zoster vaccine reduces the risk of heart disease by 23%. This finding suggests a significant additional benefit of the vaccine. The study, published in the European Heart Journal, analyzed over 1.2 million people aged 50 and older. Researchers found the risk reduction was most noticeable within eight years of vaccination, particularly in men and those under 60. The study's findings could encourage more people to get vaccinated. The research used an older version of the vaccine, and further studies are needed to compare it to newer versions.